Aspirin Use For CVD Prevention Low Among At-Risk Patients – Study
This article was originally published in The Tan Sheet
Executive Summary
A survey on aspirin use for cardiovascular disease prevention shows low usage "even among patients at increased risk" and could encourage FDA to act on a Bayer's 2003 citizen petition to include a primary prevention indication in professional labeling for aspirin, a researcher says